Retatrutide is a new treatment in the fight against obesity. This groundbreaking drug, categorized as a dual GLP-1 and GIP receptor agonist, demonstrates promising results in investigations. By activating these https://shaunanugc084068.webbuzzfeed.com/36674421/tirzepatide-a-promising-new-treatment-for-obesity